Zoetis (ZTS) Amortization - Intangibles (2012 - 2026)
Zoetis' (ZTS) quarterly Amortization - Intangibles came in at $31.0 million in Q1 2026, down 3.12% year-on-year from $32.0 million in Q1 2025, and down 48.33% on a QoQ basis from $60.0 million in Q4 2025.
Zoetis (ZTS) Amortization - Intangibles (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 13 years of Amortization - Intangibles data on file, last reported at $31.0 million in Q1 2026.
- On a quarterly basis, Amortization - Intangibles fell 3.12% year-over-year to $31.0 million in Q1 2026; TTM through Mar 2026 was $171.0 million, a 18.75% increase from a year earlier, with the FY2025 full-year figure at $157.0 million, down 7.65% from the prior year.
- Amortization - Intangibles for Q1 2026 stood at $31.0 million, down from $60.0 million in the prior quarter.
- Over the last five years, Amortization - Intangibles for ZTS reached as high as $60.0 million in Q4 2025 and fell as low as $8.0 million in Q4 2023.
- Historically, Amortization - Intangibles has averaged $38.5 million across 5 years, with a median of $37.0 million in 2022.
- Across the five-year window, Amortization - Intangibles tumbled 82.61% in 2023 and surged 425.0% in 2024, its largest moves.
- Year by year, Amortization - Intangibles stood at $46.0 million in 2022, then tumbled by 82.61% to $8.0 million in 2023, then jumped by 425.0% to $42.0 million in 2024, then soared by 42.86% to $60.0 million in 2025, then plunged by 48.33% to $31.0 million in 2026.
- Per Business Quant data, the three most recent Amortization - Intangibles figures were $31.0 million in Q1 2026, $60.0 million in Q4 2025, and $39.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.00 Mn |
| Dec 31, 2025 | 60.00 Mn |
| Sep 30, 2025 | 39.00 Mn |
| Jun 30, 2025 | 41.00 Mn |
| Mar 31, 2025 | 32.00 Mn |
| Dec 31, 2024 | 42.00 Mn |
| Sep 30, 2024 | 35.00 Mn |
| Jun 30, 2024 | 35.00 Mn |
| Mar 31, 2024 | 37.00 Mn |
| Dec 31, 2023 | 8.00 Mn |
| Sep 30, 2023 | 38.00 Mn |
| Jun 30, 2023 | 48.00 Mn |
| Mar 31, 2023 | 37.00 Mn |
| Dec 31, 2022 | 46.00 Mn |
| Sep 30, 2022 | 37.00 Mn |
| Jun 30, 2022 | 37.00 Mn |
| Mar 31, 2022 | 52.00 Mn |
| Dec 31, 2021 | 50.00 Mn |
| Sep 30, 2021 | 40.00 Mn |
| Jun 30, 2021 | 41.00 Mn |